A prospective, parallel group, interventional and open label study to evaluate the effect of probiotics on glycemic control in pre-diabetic patients

Anjalika Brar; Ajay Chhabra; Navyug Raj Singh

doi:10.18203/2319-2003.ijbcp20263774

Authors

Anjalika Brar Department of Pharmacology, Government Medical College, Amritsar, Punjab, India
Ajay Chhabra Department of Medicine, Government Medical College, Amritsar, Punjab, India
Navyug Raj Singh Department of Pharmacology, Government Medical College, Amritsar, Punjab, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20263774

Keywords:

Prediabetes, Probiotics, Glycemic control, Fasting plasma glucose, Lipid profile

Abstract

Background: Prediabetes represents an intermediate metabolic state characterized by impaired glucose tolerance and a high risk of progression to diabetes. With rising global burden of diabetes, early interventions are essential. Emerging evidence suggests that gut microbiota plays a significant role in metabolism and probiotics may offer a novel and safe therapeutic approach.

Methods: This prospective, parallel-group, interventional and open-label study was conducted on 70 prediabetic patients. Participants were divided into two groups: Group A received a probiotic capsule containing Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium longum and Saccharomyces boulardii (2.5 billion CFU) once daily along with diet control as per American Diabetes Association recommendations, while Group B was advised only diet control for 90 days. Fasting Plasma Glucose (FPG), 2-Hour Plasma Glucose (2HPG) and HbA1c were assessed as primary objectives along with Total cholesterol, LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), Serum Triglycerides, Body weight and BMI as secondary objectives. Safety was evaluated through monitoring of adverse events.

Results: Probiotic supplementation along with diet control resulted in statistically significant reduction in mean FPG (p=0.018) within group A. There was a statistically non-significant difference in change in FPG (p=0.28), 2HPG (p=0.48) and HbA1c (p=0.17) between group A and B. Statistically significant difference was seen in reduction in mean Total cholesterol (p=0.01), LDL-C (p=0.009), body weight (p=0.03) and BMI (p=0.03), increase in mean HDL - C (p=0.006) and a statistically non-significant difference in change in mean Triglyceride (p=0.17) levels between group A and B. The intervention was well tolerated, with minimal and non-serious adverse events reported.

Conclusions: Probiotic supplementation did not provide a significant additional benefit over diet control in improving glycemic parameters in prediabetic patients. However, it resulted in significant improvement in lipid profile, body weight and BMI. Both interventions were well tolerated with comparable safety profiles.

References

Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):2932–8.

Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: an overview. Avicenna J Med. 2020;10(4):174-88.

American Heart Association. Diabetes risk factors. Available from: https://www.heart.org/en/health-topics/diabetes/understand-your-risk-for-diabetes Accessed on 26 July 2026.

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.

American Diabetes Association. Diabetes diagnosis and tests. Available from: https://diabetes.org/about-diabetes/diagnosis Accessed on 26 July 2026.

Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for developing diabetes. Lancet. 2012;379(9833):2279–90.

Bacha F, Hannon TS, Tosur M, Pike JM, Butler A, Tommerdahl KL, et al. Pathophysiology and treatment of prediabetes and type 2 diabetes in youth. Diabetes Care. 2024;47(12):2038–49.

Gadelha CJMU, Bezerra AN. Effects of probiotics on the lipid profile: systematic review. J Vasc Bras. 2019;18:e20180124.

Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M. Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med. 2013;3(3):a010074.

Latif A, Shehzad A, Niazi S, Zahid A, Ashraf W, Iqbal MW, et al. Probiotics: mechanism of action, health benefits and their application in food industries. Front Microbiol. 2023;14:1216674.

Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12:578386.

Viana MDM, Santos SS, Cruz ABO, de Jesus MVAC, Lauria PSS, Lins MP, et al. Probiotics as antioxidant strategy for managing diabetes mellitus and its complications. Antioxidants (Basel). 2025;14(7):767.

AkbariRad M, Shariatmaghani SS, Razavi BM, Majd HM, Shakhsemampour Z, Sarabi M, et al. Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study. Diabetol Metab Syndr. 2023;15(1):71.

Jiang H, Zhang Y, Xu D, Wang Q. Probiotics ameliorate glycemic control in patients with diabetic nephropathy: a randomized clinical study. J Clin Lab Anal. 2021;35(4):e23650.

Kadeer G, Fu W, He Y, Feng Y, Liu WH, Hung WL, et al. Effect of different doses of Lacticaseibacillus paracasei K56 on body fat and metabolic parameters in adult individuals with obesity: a pilot study. Nutr Metab (Lond). 2023;20(1):16.

Zhang WX, Shi LB, Zhou MS, Wu J, Shi HY. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. J Med Microbiol. 2023;72(9):001758.

American Diabetes Association Professional Practice Committee. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Suppl 1):S60–82.

Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42(5):731–54.

Mo R, Zhang X, Yang Y. Effect of probiotics on lipid profiles in hypercholesterolaemic adults: a meta-analysis of randomized controlled trials. Med Clin (Barc). 2019;152(12):473–81.

Guo M, Li J, Zhang L, Chen C, Wei Y, Shen ZA. Effects of oral supplementation of probiotics on body weight and visceral fat in obese patients: a meta-analysis and systematic review. Sci Rep. 2025;15(1):6355.

Sudha MR, Ahire JJ, Jayanthi N, Tripathi A, Nanal S. Effect of multi-strain probiotic (UB0316) in weight management in overweight/obese adults: a 12-week double blind, randomised, placebo-controlled study. Benef Microbes. 2019;10(8):855–66.